第一章 总则 北京诺禾致源科技股份有限公司 对外担保管理办法 二○二五年八月 北京诺禾致源科技股份有限公司 对外担保管理办法 第一条 为规范北京诺禾致源科技股份有限公司（以下简称"公司"）对外担 保管理，规范公司担保行为，控制公司经营风险，根据《中华人民共和国民法典》 《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所科创板 股票上市规则》（以下简称"《上市规则》"）、《上市公司监管指引第 8 号—— 上市公司资金往来、对外担保的监管要求》、《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》等有关法律、法规、规范性文件及《北京诺 禾致源科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，制订 本办法。 第二条 本办法所述的对外担保系指公司为债务人对于债权人所负的债务 提供担保，当债务人不履行债务时，由公司按照约定履行债务或者承担其他担保 责任的行为。担保形式包括保证、抵押及质押。 对外担保包括公司为控股子公司提供的担保。 第三条 公司股东会和董事会是对外担保的决策机构，公司一切对外担保行 为，须按程序经公司股东会或董事会批准。未经公司股东会（或董事会）的批准， 公司不 ...

董事会议事规则 二○二五年八月 北京诺禾致源科技股份有限公司 董事会议事规则 第一章 总则 第一条 为了进一步规范北京诺禾致源科技股份有限公司（下称"公司"或 "本公司"）董事会的议事方式和决策程序，促使董事和董事会有效地履行其职 责，提高董事会规范运作和科学决策水平，根据《中华人民共和国公司法》（下 称"《公司法》"）、《中华人民共和国证券法》《上市公司治理准则》《上海 证券交易所科创板股票上市规则》等法律、行政法规、规范性文件的规定和《北 京诺禾致源科技股份有限公司章程》（下称"《公司章程》"）等有关规定，制 订本规则。 第二条 董事会秘书负责董事会会议的筹备，并负责会议的记录及会议通知、 表决票、决议、会议记录等会议文件的保管。 第二章 董事会会议的召开 北京诺禾致源科技股份有限公司 第三条 董事会会议分为定期会议和临时会议。 董事会每年度至少召开两次定期会议。 第四条 在发出召开董事会定期会议的通知前，董事会秘书应当充分征求各 董事的意见，初步形成会议提案后交董事长拟定。 董事长在拟定提案前，应当视需要征求总经理和其他高级管理人员的意见。 第五条 有下列情形之一的，董事会应当召开临时会议： （一）代表 ...

格隆汇8月14日丨诺禾致源(688315.SH)公布2025年半年度报告，上半年公司实现营业收入10.40亿元，同 比增长4.36%；利润总额9192.06万元，同比下降2.73%；归属于上市公司股东的净利润7872.96万元，同 比增长1.03%；归属于上市公司股东的扣除非经常性损益的净利润6293.48万元，同比下降4.52%；基本 每股收益0.19元。 ...

Core Viewpoint - The company, 诺禾致源, has completed a share reduction plan by its shareholders, resulting in a total reduction of 8,077,677 shares, which is 2.94% of its total share capital [1][2]. Share Reduction Details - The shareholders, 致源禾谷 and 诺禾禾谷, reduced their holdings through centralized bidding and block trading, with a total of 2,898,677 shares (0.70%) and 5,179,000 shares (1.24%) sold respectively [1]. - The reduction occurred between April 16, 2025, and July 15, 2025, at prices ranging from 12.83 yuan to 14.99 yuan per share, totaling approximately 110.26 million yuan [1]. Shareholder Background - Prior to the reduction, 致源禾谷 held 47,106,622 shares (11.32%) and 诺禾禾谷 held 12,564,672 shares (3.02%) of 诺禾致源 [2]. - The controlling shareholder, 李瑞强, is a general partner of both 致源禾谷 and 诺禾禾谷, indicating they are acting in concert [2]. Initial Public Offering (IPO) and Fundraising - 诺禾致源 raised a total of 51.30 million yuan from its IPO, with a net amount of 44.98 million yuan after deducting issuance costs [3]. - The company planned to use the funds for projects related to gene sequencing service platform expansion, gene testing reagent development, and information technology infrastructure [3]. - In 2023, the company conducted a private placement, raising 332.16 million yuan, with a net amount of 327.61 million yuan after expenses [4]. - The total fundraising from the IPO and the 2023 private placement amounts to 84.51 million yuan [5].

Core Viewpoint - The announcement details the share reduction results of the shareholders of Nuohe Zhiyuan, specifically Beijing Zhiyuan Hegu Investment Management Center and Beijing Nuohe Hegu Investment Management Center, outlining their shareholding changes and reduction plans [1][3]. Shareholding Situation Before Reduction - Before the reduction plan, Zhiyuan Hegu held 47,106,622 shares, accounting for 11.32% of the total shares of Nuohe Zhiyuan. Nuohe Hegu held 12,564,672 shares, representing 3.02% of the total shares. Together, they held 59,671,294 shares, which is 14.34% of the total shares, all acquired before the company's initial public offering and set to be tradable from April 15, 2024 [2]. Reduction Plan and Implementation Results - On March 20, 2025, Nuohe Zhiyuan disclosed a reduction plan, where Zhiyuan Hegu and Nuohe Hegu planned to reduce a total of up to 12,486,000 shares, representing 3% of the total shares. This included a maximum of 4,162,000 shares through centralized bidding (up to 1%) and 8,324,000 shares through block trading (up to 2%). As of July 15, 2025, they had reduced 2,898,677 shares through centralized bidding (0.70% of total shares) and 5,179,000 shares through block trading. The total reduction completed was 8,077,677 shares, or 1.94% of total shares, with a reduction price range of 12.83 to 14.99 yuan per share, totaling 110,264,756.78 yuan. Post-reduction, they held a combined total of 51,593,617 shares, which is 12.40% of the total shares [3].

证券代码：688315 证券简称：诺禾致源 公告编号：2025-030 北京诺禾致源科技股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持股的基本情况 本次减持计划实施前，北京诺禾致源科技股份有限公司（以下简称"公司" 或"诺禾致源"）股东北京致源禾谷投资管理中心（有限合伙）（以下简称"致源 禾谷"）持有公司 47,106,622 股股份，占公司总股份的 11.32%；北京诺禾禾谷投 资管理中心（有限合伙）（以下简称"诺禾禾谷"）持有公司 12,564,672 股股份， 占公司总股份的 3.02%。上述股份为致源禾谷和诺禾禾谷于公司首次公开发行并 上市前取得的股份，且于 2024 年 4 月 15 日起上市流通。 减持计划的实施结果情况 公司于 2025 年 3 月 20 日在上海证券交易所网站（www.sse.com.cn）披露了 《北京诺禾致源科技股份有限公司股东减持股份计划公告》（公告编号： 2025-006）。致源禾谷和诺禾禾谷计划通过集中竞价、 ...

诺禾致源公告，公司股东致源禾谷和诺禾禾谷的减持计划已实施完毕。截至2025年7月15日，致源禾谷 和诺禾禾谷通过集中竞价交易方式累计减持289.87万股，占公司总股本的0.70%；通过大宗交易方式累 计减持517.9万股，占公司总股本的1.24%。本次减持计划合计减持807.77万股，占公司总股本的 1.94%。减持后，致源禾谷和诺禾禾谷合计持股比例降至12.40%。 ...

Core Viewpoint - The announcement highlights the equity changes of major shareholders in Nuohe Zhiyuan, indicating a reduction in their holdings, which may impact the company's stock performance and investor sentiment [1][2]. Shareholder Equity Changes - Beijing Zhiyuan Hegu Investment Management Center reduced its holdings by 2,077,773 shares (0.50%) through centralized bidding and 2,179,000 shares (0.52%) through block trading, decreasing its ownership from 11.32% to 10.30% [1][2]. - Beijing Nuohe Hegu Investment Management Center reduced its holdings by 217,488 shares (0.05%) through centralized bidding, with no shares sold through block trading, decreasing its ownership from 3.02% to 2.97% [1][2]. Total Shares Reduced - Between April 21, 2025, and June 3, 2025, a total of 4,474,261 shares were sold by both Zhiyuan Hegu and Nuohe Hegu [2]. Company Background - Nuohe Zhiyuan was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 13, 2021, with an initial public offering (IPO) of 40.2 million shares at a price of 12.76 yuan per share, raising a total of 51,295.20 million yuan [2][3]. - The company intended to use the IPO proceeds for projects related to gene sequencing service platform expansion, gene testing reagent research and development, information technology and data center construction, and working capital [2]. Recent Fundraising Activities - In October 2023, Nuohe Zhiyuan announced a private placement of 16 million shares at a price of 20.76 yuan per share, raising a total of 332.16 million yuan, with net proceeds of approximately 327.61 million yuan after deducting issuance costs [3]. - The total fundraising from the IPO and the 2023 private placement amounts to 84,511.2 million yuan [4].

管 理 中 心 1,256.4672 3.02% 1,234.7184 2.97% □大宗交易 / | 证券代码：688315 证券简称：诺禾致源 公告编号：2025-029 | | | --- | --- | | 北京诺禾致源科技股份有限公司 | | | 关于持股 5%以上股东权益变动触及 1%刻度的提示性 | | | 公告 | | | 股东北京致源禾谷投资管理中心（有限合伙）、北京诺禾禾谷投资管理中心（有限 | | | 合伙）及其一致行动人李瑞强保证向本公司提供的信息真实、准确、完整，没有虚假记 | | | 载、误导性陈述或重大遗漏。 | | | 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 | | | 重要内容提示： | | | 权益变动方向 比例增加□ 比例减少? | | | 权益变动前合计比例 65.95% | | | 权益变动后合计比例 64.87% | | | 本次变动是否违反已作出的承诺、意向、计划 是□ 否? | | | 是□ 否? 是否触发强制要约收购义务 | | | 一、 信息披露义务人及其一致行动人的基本信息 | | | ?控股股东/实际控制人及其一致行动人 | ...

Core Viewpoint - The company, Beijing Novogene Technology Co., Ltd., has announced a differentiated cash dividend distribution plan, proposing a cash dividend of RMB 0.05 per share (tax included) for the fiscal year 2024, approved at the annual shareholders' meeting on May 7, 2025 [1][2]. Summary by Sections Dividend Distribution Plan - The company plans to distribute a cash dividend of RMB 0.05 per share to all shareholders, based on the total share capital minus the shares held in the company's repurchase account [2][3]. - As of the announcement date, the total share capital is 416,200,000 shares, with 11,141,468 shares in the repurchase account, resulting in 405,058,532 shares eligible for distribution, totaling approximately RMB 20,252,926.60 (tax included) [2][3]. Ex-Dividend Date and Payment - The ex-dividend date, record date, and cash dividend payment date are specified, with the cash dividend being distributed through the China Securities Depository and Clearing Corporation Limited [3][4]. Tax Implications - For individual shareholders and securities investment funds, dividends are subject to different tax treatments based on the holding period, with a maximum tax rate of 20% for shares held for less than one month, and no tax for shares held over one year [4][5]. - For qualified foreign institutional investors (QFII), a withholding tax of 10% applies, resulting in a net cash dividend of RMB 0.045 per share [5][6]. - Other corporate shareholders are responsible for their own tax declarations, with the gross cash dividend being RMB 0.05 per share [6].